Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer

Original Article from The New England Journal of Medicine - Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer

Saved in:

Bibliographic Details
Main Authors:	Schmid, Peter (Author) , Adams, Sylvia (Author) , Rugo, Hope S. (Author) , Schneeweiss, Andreas (Author) , Barrios, Carlos H. (Author) , Iwata, Hiroji (Author) , Diéras, Véronique (Author) , Hegg, Roberto (Author) , Im, Seock-Ah (Author) , Wright, Gail Shaw (Author) , Henschel, Volkmar (Author) , Molinero, Luciana (Author) , Chui, Stephen Y. (Author) , Funke, Roel (Author) , Husain, Amreen (Author) , Winer, Eric P. (Author) , Loi, Sherene (Author) , Emens, Leisha A. (Author)
Format:	Article (Journal)
Language:	English
Published:	October 20, 2018
In:	The New England journal of medicine Year: 2018, Volume: 379, Pages: 2108-2121
ISSN:	1533-4406
DOI:	10.1056/NEJMoa1809615
Online Access:	Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1056/NEJMoa1809615 Verlag, lizenzpflichtig, Volltext: https://www.nejm.org/doi/10.1056/NEJMoa1809615
Author Notes:	Peter Schmid, Sylvia Adams, Hope S. Rugo, Andreas Schneeweiss, Carlos H. Barrios, Hiroji Iwata, Véronique Diéras, Roberto Hegg, Seock-Ah Im, Gail Shaw Wright, Volkmar Henschel, Luciana Molinero, Stephen Y. Chui, Roel Funke, Amreen Husain, Eric P. Winer, Sherene Loi, and Leisha A. Emens, for the IMpassion130 Trial Investigators

Description
Summary:	Original Article from The New England Journal of Medicine - Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
Item Description:	This article was published on October 20, 2018, and updated on November 15, 2018, at NEJM.org Gesehen am 21.04.2020
Physical Description:	Online Resource
ISSN:	1533-4406
DOI:	10.1056/NEJMoa1809615